Sangui Biotech International, Inc.

SGBI · OTC
Analyze with AI
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Activities
Net Income-$148-$63-$204
Dep. & Amort.$14$22-$18
Deferred Tax$0$0$0
Stock-Based Comp.$0$0$0
Change in WC$5-$3$42
Other Non-Cash$117-$96$35
Operating Cash Flow-$12-$140-$146
Investing Activities
PP&E Inv.$0$0$0
Net Acquisitions$0$0$0
Inv. Purchases$0$0$0
Inv. Sales/Matur.$0$0$0
Other Inv. Act.$0$0$0
Investing Cash Flow$0$0$0
Financing Activities
Debt Repay.$0$68$102
Stock Issued$0$28$61
Stock Repurch.$0$0$0
Dividends Paid$0$0$0
Other Fin. Act.$0$75$0
Financing Cash Flow$0$142$162
Forex Effect-$16-$1-$2
Net Chg. in Cash-$28$1$14
Supplemental Information
Beg. Cash$30$30$15
End Cash$3$30$30
Free Cash Flow-$12-$140-$146
Sangui Biotech International, Inc. (SGBI) Financial Statements & Key Stats | AlphaPilot